Precision Medicine Summit
Why now is the perfect time for precision medicine?
· Emerging technologies have fast-tracked advances in medicine
· Global Covid-10 pandemic has galvanised medical research
· Middle Eastern populations have much to gain from targeted therapies
Dubai, UAE, 3rd May 2022: Recent technological advances provide a significant stimulus to the field of precision medicine, fast-tracking disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle.
The ongoing Covid-19 pandemic has driven significant new investment into pioneering medical research, and an initial broadly applied global response has begun to shift towards more targeted treatments across specific populations.
As the Middle East’s first and only event dedicated to precision medicine, the PrecisionMed Exhibition & Summit, held on May 24 and 25 in Dubai, brings an unprecedented regional focus on the fast-evolving world of personalised medicine.
It offers an unrivalled opportunity for healthcare providers, researchers, public sector buyers and influencers from across this ecosystem in the GCC to catch up on the latest developments, opportunities and outcomes within this dynamic area of disease prevention, diagnostics and treatment.
“We are excited to bring an unparalleled line-up of distinguished speakers to the Middle East to focus on how scientific advances significantly impact human health,” says event director David Stradling. “This comes at a time when governments in the region are concentrated more than ever on improving healthcare systems for their populations and seeking to optimise healthcare outcomes and costs.”
According to research and markets, funding for precision medicine saw a sharp uptick in 2020 to help address the challenges of Covid-19. It forecasts significant growth across the sector as the pandemic has highlighted the need for urgent, effective treatments and accurate diagnostic tools.
Precision medicine is a fast-growing area – the market is estimated to reach about US$126 billion in value by the year 2025, a compound annual growth rate of 12.48% between 2017 and 2025, according to Market Research Future.
The field allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
The evolving world of personalised medicine includes biomarkers, targeted therapies and the integration of patient health data to translate scientific advances